390
Views
0
CrossRef citations to date
0
Altmetric
Neurology

Exploration of the risk factor for infarction after revascularization in moyamoya disease

ORCID Icon, , , , , , , ORCID Icon & ORCID Icon show all
Article: 2362872 | Received 06 Nov 2023, Accepted 02 May 2024, Published online: 24 Jun 2024

References

  • Ihara M, Yamamoto Y, Hattori Y, et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol. 2022;21(8):1–11. doi: 10.1016/S1474-4422(22)00165-X.
  • Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–299. doi: 10.1001/archneur.1969.00480090076012.
  • Ha EJ, Kim KH, Wang KC, et al. Long-term outcomes of indirect bypass for 629 children with moyamoya disease: longitudinal and cross-sectional analysis. Stroke. 2019;50(11):3177–3183. doi: 10.1161/STROKEAHA.119.025609.
  • Jeon JP, Kim JE, Cho WS, et al. Meta-analysis of the surgical outcomes of symptomatic moyamoya disease in adults. J Neurosurg. 2018;128(3):793–799. doi: 10.3171/2016.11.JNS161688.
  • Guo Q, Pei S, Wang QN, et al. Risk factors for preoperative cerebral infarction in infants with moyamoya disease. Transl Stroke Res. 2023. doi: 10.1007/s12975-023-01167-z.
  • Takasu S, Kanamori F, Hatano N, et al. Effects of superficial temporal artery to middle cerebral artery bypass on postoperative infarction rates among young children ( < / =  5 years old) with moyamoya disease. Neurosurg Rev. 2023;46(1):87. doi: 10.1007/s10143-023-01999-1.
  • Chen Y, Ma L, Lu J, et al. Postoperative hemorrhage during the acute phase after direct or combined revascularization for moyamoya disease: risk factors, prognosis, and literature review. J Neurosurg. 2019;133(5):1450–1459. doi: 10.3171/2019.7.JNS19885.
  • Nomura S, Kawashima A, Ishiguro T, et al. Five-day bed rest reduces postoperative intracerebral hemorrhage after direct bypass for moyamoya disease. World Neurosurg. 2022;159:e267–e272. doi: 10.1016/j.wneu.2021.12.043.
  • Pang CH, Lee SU, Lee Y, et al. Prediction of hemorrhagic cerebral hyperperfusion syndrome after direct bypass surgery in adult nonhemorrhagic moyamoya disease: combining quantitative parameters on rapid perfusion CT with clinically related factors. J Neurosurg. 2023;138(3):683–692. doi: 10.3171/2022.5.JNS212838.
  • Kim KM, Kim JE, Cho WS, et al. Natural history and risk factor of recurrent hemorrhage in hemorrhagic adult moyamoya disease. Neurosurgery. 2017;81(2):289–296. doi: 10.1093/neuros/nyw179.
  • Zhang Q, Yin Z, Zhu C, et al. Effectiveness of indirect revascularization for adult hemorrhagic moyamoya disease: a 10-year follow-up study. J Neurosurg. 2023;140(3):764–773. doi: 10.3171/2023.6.JNS23727.
  • Guzman R, Lee M, Achrol A, et al. Clinical outcome after 450 revascularization procedures for moyamoya disease [Clinical article]. J Neurosurg. 2009;111(5):927–935. doi: 10.3171/2009.4.JNS081649.
  • Health Labour Sciences Research Grant for Research on Measures for Infractable Diseases. Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis. Neurol Med Chir. 2012;52(5):245–266. doi: 10.2176/nmc.52.245.
  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339.
  • Elsayed NA, Aleppo G, Aroda VR, et al. On, 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46(9):1715–1S40. doi: 10.2337/dc23-S002.
  • Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (poise trial): a randomised controlled trial. Lancet. 2008;371(9627):1839–1847. doi: 10.1016/S0140-6736(08)60601-7.
  • Wei W, Chen X, Yu J, et al. Risk factors for postoperative stroke in adults patients with moyamoya disease: a systematic review with meta-analysis. BMC Neurol. 2019;19(1):98. doi: 10.1186/s12883-019-1327-1.
  • Park W, Ahn JS, Lee HS, et al. Risk factors for newly developed cerebral infarction after surgical revascularization for adults with moyamoya disease. World Neurosurg. 2016;92:65–73. doi: 10.1016/j.wneu.2016.03.053.
  • Mineharu Y, Takagi Y, Koizumi A, et al. Genetic and nongenetic factors for contralateral progression of unilateral moyamoya disease: the first report from the Supra Japan Study Group. J Neurosurg. 2022;136(4):1005–1014. doi: 10.3171/2021.3.JNS203913.
  • Scala M, Fiaschi P, Capra V, et al. When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with rasopathies? A systematic review of the literature and a single institute experience. Childs Nerv Syst. 2018;34(7):1311–1323. doi: 10.1007/s00381-018-3833-7.
  • Fiaschi P, Scala M, Piatelli G, et al. Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome. Neurosurg Rev. 2021;44(4):1877–1887. doi: 10.1007/s10143-020-01393-1.
  • Scala M, Fiaschi P, Cama A, et al. Radiation-induced moyamoya syndrome in children with brain tumors: case series and literature review. World Neurosurg. 2020;135:118–129. doi: 10.1016/j.wneu.2019.11.155.
  • Sun J, Li ZY, Chen C, et al. Postoperative neovascularization, cerebral hemodynamics, and clinical prognosis between combined and indirect bypass revascularization procedures in hemorrhagic moyamoya disease. Clin Neurol Neurosurg. 2021;208:106869. doi: 10.1016/j.clineuro.2021.106869.
  • Hara S, Nariai T, Inaji M, et al. Imaging pattern and the mechanisms of postoperative infarction after indirect revascularization in patients with moyamoya disease. World Neurosurg. 2021;155:e510–e521. doi: 10.1016/j.wneu.2021.08.098.
  • Araki Y, Uda K, Yokoyama K, et al. Risk factors for cerebral infarction early after revascularization in children younger than 5 years with moyamoya disease. World Neurosurg. 2022;160:e220–e226. doi: 10.1016/j.wneu.2021.12.115.
  • Zhao M, Deng X, Zhang D, et al. Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease. J Neurosurg. 2018;130(2):531–542. doi: 10.3171/2017.10.JNS171749.
  • Dauser RC, Tuite GF, Mccluggage CW. Dural inversion procedure for moyamoya disease. Technical note. J Neurosurg. 1997;86(4):719–723. doi: 10.3171/jns.1997.86.4.0719.
  • Cho H, Jo KI, Yu J, et al. Low flow velocity in the middle cerebral artery predicting infarction after bypass surgery in adult moyamoya disease. J Neurosurg. 2017;126(5):1573–1577. doi: 10.3171/2016.3.JNS152256.
  • Hayashi T, Shirane R, Fujimura M, et al. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr. 2010;6(1):73–81. doi: 10.3171/2010.4.PEDS09478.
  • Kazumata K, Ito M, Tokairin K, et al. The frequency of postoperative stroke in moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg. 2014;121(2):432–440. doi: 10.3171/2014.1.JNS13946.
  • El NK, Chen CJ, Jabre R, et al. Direct versus indirect revascularization for moyamoya: a large multicenter study. J Neurol Neurosurg Psychiatry. 2023:jnnp-2022-329176. doi: 10.1136/jnnp-2022-329176.
  • Hyun SJ, Kim JS, Hong SC. Prognostic factors associated with perioperative ischemic complications in adult-onset moyamoya disease. Acta Neurochir. 2010;152(7):1181–1188. doi: 10.1007/s00701-010-0638-1.
  • Li J, Zhao Y, Zhao M, et al. High variance of intraoperative blood pressure predicts early cerebral infarction after revascularization surgery in patients with moyamoya disease. Neurosurg Rev. 2020;43(2):759–769. doi: 10.1007/s10143-019-01118-z.
  • Kim SK, Wang KC, Kim IO, et al. Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo (periosteal) synangiosis in pediatric moyamoya disease. Neurosurgery. 2002;50(1):88–96. doi: 10.1097/00006123-200201000-00016.
  • Miyatake S, Miyake N, Touho H, et al. Homozygous c.14576g > a variant of rnf213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803–810. doi: 10.1212/WNL.0b013e318249f71f.
  • Zhang XG, Zhang YQ, Zhao DK, et al. Relationship between blood glucose fluctuation and macrovascular endothelial dysfunction in type 2 diabetic patients with coronary heart disease. Eur Rev Med Pharmacol Sci. 2014;18(23):3593–3600.
  • Yu Z, Bai X, Zhang Y, et al. Baseline hemodynamic impairment and revascularization outcome in newly diagnosed adult moyamoya disease determined by pseudocontinuous arterial spin labeling. World Neurosurg. 2022;165:e494–e504. doi: 10.1016/j.wneu.2022.06.084.
  • Filimonova E, Ovsiannikov K, Rzaev J. Neuroimaging in moyamoya angiopathy: updated review. Clin Neurol Neurosur. 2022;222:107471. doi: 10.1016/j.clineuro.2022.107471.
  • Watchmaker JM, Frederick BD, Fusco MR, et al. Clinical use of cerebrovascular compliance imaging to evaluate revascularization in patients with moyamoya. Neurosurgery. 2019;84(1):261–271. doi: 10.1093/neuros/nyx635.
  • L WS, Garza M, Davis LT, et al. Presurgical magnetic resonance imaging indicators of revascularization response in adults with moyamoya vasculopathy. J Magn Reson Imaging. 2022;56(4):983–994. doi: 10.1002/jmri.28156.
  • Yun TJ, Cheon JE, Na DG, et al. Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging–correlation with clinical outcome after revascularization surgery. Radiology. 2009;251(1):216–223. doi: 10.1148/radiol.2511080654.
  • Rios-Zermeno J, Ghaith AK, El HV, et al. Extracranial-intracranial bypass for moyamoya disease: the influence of racial and socioeconomic disparities on outcomes - a national inpatient sample analysis. World Neurosurg. 2023;182:e624–e634. doi: 10.1016/j.wneu.2023.12.005.
  • Raygor KP, Phelps R, Rutledge C, et al. Socioeconomic factors associated with pediatric moyamoya disease hospitalizations: a nationwide cross-sectional study. J Neurosurg Pediatr. 2022;29(6):602–611. doi: 10.3171/2022.1.PEDS21339.
  • Ghaffari-Rafi A, Ghaffari-Rafi S, Leon-Rojas J. Socioeconomic and demographic disparities of moyamoya disease in the United States. Clin Neurol Neurosurg. 2020;192:105719. doi: 10.1016/j.clineuro.2020.105719.
  • Winkler EA, Yue JK, Deng H, et al. National trends in cerebral bypass surgery in the United States, 2002-2014. Neurosurg Focus. 2019;46(2):E4. doi: 10.3171/2018.11.FOCUS18530.
  • Choi JW, Chong S, Phi JH, et al. Postoperative symptomatic cerebral infarction in pediatric moyamoya disease: risk factors and clinical outcome. World Neurosurg. 2020;136:e158–e164. doi: 10.1016/j.wneu.2019.12.072.
  • Kim SH, Choi JU, Yang KH, et al. Risk factors for postoperative ischemic complications in patients with moyamoya disease. J Neurosurg. 2005;103(5 Suppl):433–438. doi: 10.3171/ped.2005.103.5.0433.